CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | +100.0% | 599 | +103.1% | 0.00% | – |
| Q1 2022 | $2,000 | -80.0% | 295 | -79.9% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 1,465 | -30.8% | 0.00% | – |
| Q3 2021 | $11,000 | -15.4% | 2,116 | -5.1% | 0.00% | – |
| Q2 2021 | $13,000 | +30.0% | 2,229 | +5.3% | 0.00% | – |
| Q1 2021 | $10,000 | – | 2,116 | +1566.1% | 0.00% | – |
| Q4 2020 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |